Interview Chairperson & GM, Amaran Biotech by Pharmaboardroom

Tessie Che, chairperson & GM of Amaran Biotech shares the story of how she came to lead the company and set its course to become a leading specialty biopharma CMO that leverages high-quality products and best manufacturing practices above all else. As a veteran in the life sciences and pharma industries, Che also shares her insights on the major trends shaping biopharma in Taiwan and internationally. Finally, Che concludes with a message about Amaran’s ambitions to set the gold standard for Taiwanese drug production.

Read More »

Amaran Biotech receives PIC/s GMP certification

Amaran Biotechnology, Inc. has been awarded cGMP certification from the Taiwan Food and Drug Administration (TFDA). The certificate demonstrates that Amaran Biotechnology manufactures and maintains a level of compliance in accordance with the Pharmaceutical Inspection Convention/Co-Operation Scheme (PIC/s) Guide to Good Manufacturing Practice (GMP). Its scope covers the manufacture of active pharmaceutical ingredients (API) at Amaran’s manufacturing facility, which is located in Hsinchu Biomedical Science Park.

Read More »

Amaran Biotechnology Selects Stellar KLH for Cancer Vaccines

Amaran Biotechnology, Inc., a biopharmaceuticals manufacturer and leading manufacturer of a key protein utilized in immunotherapy development pipelines Stellar Biotechnologies, Inc. (Nasdaq: SBOT), have entered into an exclusive multi-year supply agreement in connection with clinical development studies of immunotherapies for metastatic breast cancer and other cancers.

Read More »